Search Results - "SEMVUA, Hadija H"

Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania by Mbuya, Alexander W, Mboya, Innocent B, Semvua, Hadija H, Mamuya, Simon H, Msuya, Sia E

“…Tuberculosis (TB) is among diseases of global health importance with Sub Saharan Africa (SSA) accounting for 25% of the global TB burden. TB prevalence among…”
Get full text

Pharmacokinetics of First-Line Tuberculosis Drugs in Tanzanian Patients by TOSTMANN, Alma, MTABHO, Charles M, SEMVUA, Hadija H, VAN DEN BOOGAARD, Jossy, KIBIKI, Gibson S, BOEREE, Martin J, AARNOUTSE, Rob E

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania by Mpagama, Stellah G, Mvungi, Happiness C, Mbelele, Peter M, Semvua, Hadija H, Liyoyo, Alphonce A, de Guex, Kristen Petros, Sloan, Derek, Kibiki, Gibson S, Boeree, Martin, Phillips, Patrick P J, Heysell, Scott K

“…Adverse drug reactions (ADRs) frequently occur in patients using second-line anti-tuberculosis medicine for treatment of multidrug resistant tuberculosis…”
Get full text

Implementation and effectiveness of evriMED with short messages service (SMS) reminders and tailored feedback compared to standard care on adherence to treatment among tuberculosis patients in Kilimanjaro, Tanzania: proposal for a cluster randomized controlled trial by Sumari-de Boer, Marion, Pima, Francis M, Ngowi, Kennedy M, Chelangwa, Geoffrey M, Mtesha, Benson A, Minja, Linda M, Semvua, Hadija H, Mpagama, Stella, Mmbaga, Blandina T, Nieuwkerk, Pythia T, Aarnoutse, Rob E

“…Adherence to tuberculosis (TB) treatment is challenging because of many factors. The World Health Organization has recommended the use of digital adherence…”
Get full text

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial by Boeree, Martin J, PhD, Heinrich, Norbert, MD, Aarnoutse, Rob, PhD, Diacon, Andreas H, PhD, Dawson, Rodney, PhD, Rehal, Sunita, MSc, Kibiki, Gibson S, Prof, Churchyard, Gavin, Prof, Sanne, Ian, FRCP, Ntinginya, Nyanda E, MD, Minja, Lilian T, MD, Hunt, Robert D, BSc, Charalambous, Salome, PhD, Hanekom, Madeleine, PhD, Semvua, Hadija H, PhD, Mpagama, Stellah G, PhD, Manyama, Christina, MD, Mtafya, Bariki, MSc, Reither, Klaus, MD, Wallis, Robert S, Prof, Venter, Amour, NatDipMicr, Narunsky, Kim, MD, Mekota, Anka, PhD, Henne, Sonja, MSc, Colbers, Angela, PhD, van Balen, Georgette Plemper, PhD, Gillespie, Stephen H, Prof, Phillips, Patrick P J, PhD, Hoelscher, Michael, Prof

“…Summary Background Tuberculosis is the world's leading infectious disease killer. We aimed to identify shorter, safer drug regimens for the treatment of…”
Get full text

Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients by Mtabho, Charles M, Semvua, Hadija H, van den Boogaard, Jossy, Irongo, Constantine F, Boeree, Martin J, Colbers, Angela, Burger, David M, van Crevel, Reinout, van der Ven, Andre J A M, Kibiki, Gibson S, Tostmann, Alma, Aarnoutse, Rob E

“…Abstract Background Diabetes mellitus (DM) is associated with poor TB treatment outcome. Previous studies examining the effect of DM on TB drug concentrations…”
Get full text

Prevalence and determinants of evidence of silicosis and impaired lung function among small scale tanzanite miners and the peri-mining community in northern Tanzania by Mbuya, Alexander W, Mboya, Innocent B, Semvua, Hadija H, Mamuya, Simon H, Howlett, Patrick J, Msuya, Sia E

“…Limited data among miners in Tanzania suggests prevalence of silicosis, obstructive lung disease and restrictive lung disease to be around 1.6%, 1.9% and 8.8%…”
Get full text

Pharmacological interactions between rifampicin and antiretroviral drugs: challenges and research priorities for resource-limited settings by Semvua, Hadija H, Kibiki, Gibson S, Kisanga, Elton R, Boeree, Martin J, Burger, David M, Aarnoutse, Rob

“…Coadministration of antituberculosis and antiretroviral therapy is often inevitable in high-burden countries where tuberculosis (TB) is the most common…”
Get full text

Concentrations of respirable crystalline silica and radon among tanzanite mining communities in Mererani, Tanzania by Mbuya, Alexander W, Mboya, Innocent B, Semvua, Hadija H, Msuya, Sia E, Howlett, Patrick J, Mamuya, Simon H

“…Globally, the number of small-scale miners (SSM) is estimated to be more than 25 million, but it supports the livelihoods of around 100 million individuals. In…”
Get full text

Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting by de Sumari-de Boer, I. Marion, van den Boogaard, Jossy, Ngowi, Kennedy M., Semvua, Hadija H., Kiwango, Krisanta W., Aarnoutse, Rob E., Nieuwkerk, Pythia T., Kibiki, Gibson S.

“…HIV infected and tuberculosis (TB) patients need high levels of treatment adherence to achieve optimal treatment outcomes. We conducted a pilot-study on real…”
Get full text

Efavirenz, tenofovir and emtricitabine combined with first-line tuberculosis treatment in tuberculosis-HIV-coinfected Tanzanian patients: a pharmacokinetic and safety study by Semvua, Hadija H, Mtabho, Charles M, Fillekes, Quirine, van den Boogaard, Jossy, Kisonga, Riziki M, Mleoh, Liberate, Ndaro, Arnold, Kisanga, Elton R, van der Ven, Andre, Aarnoutse, Rob E, Kibiki, Gibson S, Boeree, Martin J, Burger, David M

“…To evaluate the effect of rifampicin-based tuberculosis (TB) treatment on the pharmacokinetics of efavirenz/tenofovir/emtricitabine in a fixed-dose combination…”
Get more information

Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania by van den Boogaard, Jossy, Semvua, Hadija H., van Ingen, Jakko, Mwaigwisya, Solomon, van der Laan, Tridia, van Soolingen, Dick, Kibiki, Gibson S., Boeree, Martin J., Aarnoutse, Rob E.

“…Objectives Fluoroquinolones are used in second-line treatment of tuberculosis (TB) and have a potential role in shortening TB treatment duration. The wide use…”
Get full text

AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus by Semvua, Hadija H, Kibiki, Gibson S

“…Co-administration of anti-tuberculosis and antiretroviral therapy is often inevitable in high-burden countries where tuberculosis is the most common…”
Get full text

Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment by van den Boogaard, Jossy, Semvua, Hadija H., Boeree, Martin J., Aarnoutse, Rob E., Kibiki, Gibson S.

“…Objectives Fluoroquinolones have a potential role in shortening tuberculosis (TB) treatment duration. They are currently used in the treatment of other…”
Get full text

Prevalence and factors associated with tuberculosis among the mining communities in Mererani, Tanzania by Alexander W. Mbuya, Innocent B. Mboya, Hadija H. Semvua, Simon H. Mamuya, Sia E. Msuya

“…Tuberculosis (TB) is among diseases of global health importance with Sub Saharan Africa (SSA) accounting for 25% of the global TB burden. TB prevalence among…”
Get full text

Atripla.sup.R.sup./anti-TB combination in TB/HIV patients. Drug in focus by Semvua, Hadija H, Kibiki, Gibson S

“…Co-administration of anti-tuberculosis and antiretroviral therapy is often inevitable in high-burden countries where tuberculosis is the most common…”
Get full text